Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Evaluation of the Protective Effect of Cystone Against Cisplatin-Induced Nephrotoxicity in Patients With Cancer: A Pilot Study Publisher



Tamadon MR1 ; Tirom S1 ; Ghahremanfard F1 ; Baradaran A2 ; Ghorbani R3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Internal Medicine, Semnan University of Medical Sciences, Semnan, Iran
  2. 2. Department of Pathology, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Social Determinants of Health Research Center, Semnan University of Medical Sciences, Semnan, Iran

Source: International Journal of Preventive Medicine Published:2019


Abstract

Introduction: Cisplatin is a widely used anti-cancer drug that is commonly administered for the treatment of various cancers. However, nephrotoxicity is the most important side effect of this drug which limits its use. This study aimed to investigate the protective effect of Cystone against nephrotoxicity induced by Cisplatin in patients with cancer. Methods: This pilot clinical trial study was conducted on 43 cancer patients treated with Cisplatin (75 mg/m2 for a period of six months). The subjects were divided into treatment group (receiving Cystone, two per 8 hours; n = 21) and control group (n = 22). The two groups were compared with each other in terms of demographic and laboratory variables. Results: In the intervention group receiving Cystone, serum creatinine-based GFR level (P = 0.453) and 24-hour urine creatinine-based GFR level (P = 0.397) did not change significantly during the studied period, but in the control group, serum creatinine-based GFR level (P = 0.013) and 24-hour urine creatinine-based GFR level (P = 0.016) significantly changed. Serum creatinine-based GFR level increased by 2.3 units in the intervention group and 10.5 units in the control group (P = 0.005) in the six months of the study. At the end of the sixth month, 24-hour urine creatinine-based GFR level increased by 2.2 units in the intervention group and 0.8 unit in the control group (P = 0.008). Conclusions: The use of Cystone resulted in more stable kidney function indices in the intervention group, as compared with the control group. Therefore, Cystone seems to have a protective effect against nephrotoxicity induced by Cisplatin in cancer patients. © 2019 International Journal of Preventive Medicine.
Other Related Docs
9. Improving Effects of Green Tea on Renal Nephrotoxicity, Journal of Isfahan Medical School (2016)
13. Soy Protein and Chronic Kidney Disease: An Updated Review, International Journal of Preventive Medicine (2017)
17. Effect of Short Hydration on Cisplatin-Induced Nephrotoxicity in Cancer Patients: A Retrospective Study, International Journal of Hematology-Oncology and Stem Cell Research (2017)
18. Cisplatin-Induced Renal Toxicity: A Short Review, Life Science Journal (2014)
35. Has Vitamin E Any Shreds of Evidence in Cisplatin-Induced Toxicity, Journal of Biochemical and Molecular Toxicology (2019)